文献速递冠心病肺血管病与心包/心肌炎

2006-2015年英国冠心病与外周动脉疾病发病率、治疗模式及结局的时间趋势

Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006-2015.
PubMed 文献 · Eur Heart J · 2020-01-01

CAD标准化发病率稳定(2006年443/10万人年 vs 2015年436/10万人年),PAD下降15%(236 vs 202/10万人年)。长期他汀使用率CAD仅66%、PAD仅55%,CAD心血管死亡率下降43%,PAD死亡率无显著下降。

要点

  • CAD标准化发病率保持稳定,PAD标准化发病率下降15%。
  • 长期他汀使用率CAD仅66%、PAD仅55%,女性和老年患者更低。
  • CAD心血管死亡率下降43%,PAD死亡率无显著下降。

核心结论

  • 英国CAD标准化发病率稳定但死亡率下降,PAD发病率下降但死亡率未下降。

主要发现

  • CAD标准化发病率2006年为443/10万人年,2015年为436/10万人年(调整IRR 0.98,95%CI 0.96-1.00)。
  • PAD标准化发病率从2006年236/10万人年降至2015年202/10万人年(调整IRR 0.85,95%CI 0.82-0.88)。
  • CAD和PAD患者长期他汀处方比例分别仅为66%和55%,女性和年龄>70岁、合并心衰、慢性肺病或抑郁者更少。
  • CAD心血管死亡率下降43%(调整IRR 0.57,95%CI 0.50-0.64),PAD无显著下降(调整IRR 0.84,95%CI 0.70-1.00)。

临床怎么用

  • 应加强CAD和PAD患者的长期他汀治疗,尤其关注女性、老年及合并症患者。
  • PAD患者死亡率未下降,需优化二级预防和综合管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Most reports estimating national incidence rates of coronary (CAD) and peripheral arterial disease (PAD) have focused on stable outpatients or acute or elective hospital admissions, but not on the overall burden of disease. In this study, we report the changing trends in the population-level incidence of CAD and PAD, respectively from 2006 to 2015, statin utilization for secondary prevention and survival outcomes using multiple nationally representative data sources from the UK (primary care encounters, hospital admissions, and procedure-level data). METHODS AND RESULTS: A nationally representative study of linked primary and secondary care electronic health records of 4.6 million individuals from the UK. We calculated crude and standardized annual incidence rates separately for CAD and PAD. Statin use for secondary prevention, trends in annual major vascular event rates, and mortality between 2006 and 2015, were estimated for CAD and PAD, respectively. We identified 160 376 and 70 753 patients with incident CAD and PAD, respectively. The age- and sex-standardized incidence of CAD was similar in 2006 (443 per 100 000 person-years) and 2015 [436 per 100 000 person-years; adjusted incidence rate ratio (IRR) 0.98, 95% confidence interval (CI) 0.96-1.00]. In contrast, there was a 15% decline in the standardized incidence of PAD (236 per 100 000 person-years in 2006 to 202 per 100 000 person-years in 2015; adjusted IRR 0.85, 95% CI 0.82-0.88). The proportion of incident CAD and PAD patients prescribed long-term statins, was only 66% and 55%, respectively and was less common amongst women, patients aged >70 years, with heart failure, chronic lung disease, or depression. Cardiovascular mortality declined by 43% for incident CAD (adjusted IRR 0.57, 95% CI 0.50-0.64) between 2006 and 2015 but did not decline for incident PAD (adjusted IRR 0.84, 95% CI 0.70-1.00). CONCLUSION AND RELEVANCE: In the UK, the standardized incidence of CAD appears stable but mortality rates are falling, whereas the standardized incidence of PAD is falling but mortality rates are not.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Sundaram V, Bloom C, Zakeri R, et al. Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006-2015. Eur Heart J. 2020. PMID: 31883328. doi:10.1093/eurheartj/ehz880

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。